BRPI0700969A - composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia - Google Patents
composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhiaInfo
- Publication number
- BRPI0700969A BRPI0700969A BRPI0700969-0A BRPI0700969A BRPI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A
- Authority
- BR
- Brazil
- Prior art keywords
- bacterial
- treatment
- composition
- inflammatory conditions
- inflammatory
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 title abstract 2
- 230000004968 inflammatory condition Effects 0.000 title abstract 2
- 241000282472 Canis lupus familiaris Species 0.000 abstract 2
- 241000282326 Felis catus Species 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 abstract 1
- 229960004099 azithromycin Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 229960001929 meloxicam Drugs 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIçãO PARA O TRATAMENTO DE AFECçõES BACTERIANAS E INFLAMATóRIAS EM ANIMAIS DE COMPANHIA. A presente invenção refere-se a uma nova composição de macrolídeo, das classes das azalídas denominado Azitromicina, associado um antiínfiamatório não esterálde, o Meloxícam, destinada para animais de companhia, particularmente em cães e gatos, para o tratamento de afecções bactenanas e inflamatónas que acometem cães e gatos Esta invenção visa proporcionar antibioticoterapia de amplo espectro, combatendo a causa das infecções, enquanto trata a inflamação e seus efeitos.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0700969-0A BRPI0700969A (pt) | 2007-03-22 | 2007-03-22 | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia |
PCT/BR2008/000085 WO2008113149A2 (en) | 2007-03-22 | 2008-03-24 | Observations where certain claims were found unsearchable |
US12/532,065 US8536143B2 (en) | 2007-03-22 | 2008-03-24 | Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0700969-0A BRPI0700969A (pt) | 2007-03-22 | 2007-03-22 | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0700969A true BRPI0700969A (pt) | 2008-11-04 |
Family
ID=39766524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0700969-0A BRPI0700969A (pt) | 2007-03-22 | 2007-03-22 | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia |
Country Status (3)
Country | Link |
---|---|
US (1) | US8536143B2 (pt) |
BR (1) | BRPI0700969A (pt) |
WO (1) | WO2008113149A2 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
WO2011107150A1 (en) * | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
CA2792647A1 (en) * | 2010-03-10 | 2011-09-15 | Nogra Pharma Limited | Compositions for colon lavage and methods of making and using same |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
CN107281155B (zh) * | 2017-06-06 | 2020-04-10 | 扬子江药业集团四川海蓉药业有限公司 | 一种阿奇霉素片及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1096862C (zh) * | 1994-05-06 | 2002-12-25 | 辉瑞大药厂 | 阿齐霉素的控释剂型 |
TW200403072A (en) | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
US20040214753A1 (en) * | 2003-03-20 | 2004-10-28 | Britten Nancy Jean | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
WO2005044254A1 (en) | 2003-10-29 | 2005-05-19 | Idexx Laboratories, Inc. | Salts of pharmacologically active compounds |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
US20060058247A1 (en) * | 2004-09-16 | 2006-03-16 | Yujiro Hata | Methods and compositions for treating cystic fibrosis |
WO2006093784A2 (en) | 2005-02-25 | 2006-09-08 | Mutual Pharmaceutical Company, Inc. | Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
-
2007
- 2007-03-22 BR BRPI0700969-0A patent/BRPI0700969A/pt not_active Application Discontinuation
-
2008
- 2008-03-24 WO PCT/BR2008/000085 patent/WO2008113149A2/en active Application Filing
- 2008-03-24 US US12/532,065 patent/US8536143B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2008113149A2 (en) | 2008-09-25 |
US20100173858A1 (en) | 2010-07-08 |
US8536143B2 (en) | 2013-09-17 |
WO2008113149A3 (en) | 2008-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0700969A (pt) | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia | |
ECSP088782A (es) | Compuestos nuevos | |
BRPI0518776A2 (pt) | composiÇço e mÉtodo para o cuidado oral, e, mÉtodos para inibir a inflamaÇço em um tecido oral de um paciente, e para promover a saéde oral em um paciente | |
BRPI0519135A2 (pt) | macrolÍdeos | |
BRPI0923855A8 (pt) | Ácido lipóico, e, composição de ração de animal de estimação | |
BRPI0407597A (pt) | propriedades anti-angiogênicas e anti-tumorais de inibidores de beta e gama secretase | |
GT200100036A (es) | Derivados de eteres de pirazol como agentes antiinflamatorios / analgesicos. | |
BRPI0608924A8 (pt) | Composição alimentícia, e, método para a criação de um animal. | |
BR112012016146A2 (pt) | uso de piruvatos na preparação de composições para animais de estimação | |
ECSP056074A (es) | Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales | |
BR112018076404A2 (pt) | mitigação de efeito de comprimento de difusão para células lógicas e posicionamento das mesmas | |
NO20076463L (no) | Synergetiske kombinasjoner | |
BR112022004036A2 (pt) | Comprimido mastigável palatável | |
BR112014011601A2 (pt) | bidens pilosa e compostos poliacetilênicos para a prevenção e para o tratamento de coccidiose | |
BRPI0813159A2 (pt) | Composição parasiticida veterinária, método para o tratamento ou controle de uma infecção ou infestação parasiticidas em um animal homeotérico, e, uso de uma composição | |
BRPI0507486A (pt) | métodos para aumentar a flexibilidade da cartilagem em um animal e para fortalecer a cartilagem em um animal, composição para fortalecer cartilagem em um animal, rações para cachorro e para gato, composições para prevenir anormalidades da cartilagem em um animal e para melhorar a flexibiladade da cartilagem em um animal, e, método para impedir a degradação da cartilagem em um animal | |
BRPI0506279A (pt) | composição sinergìstica de antihelmìnticos e endectocidas | |
BR112012025772A2 (pt) | métodos de controle e profilaxia de inflamação e mitigação de condições inflamatórias em animais de estimação | |
BR112015029260A2 (pt) | derivados de tilosina e seu método de preparação | |
AR055161A1 (es) | Combinacion de metionina biodisponible con por lo menos un aceite esencial | |
Roy et al. | Investigation of the aetiology of udder-thigh dermatitis in French dairy cattle | |
BRPI0514260A (pt) | composições alimentìcias para animais de estimação tendo uma propriedade de relaxamento definida | |
BRPI0806095A2 (pt) | associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia | |
CU20100119A7 (es) | Compuestos orgánicos de aminotiazoles | |
BR112021026797A2 (pt) | Composição alimentar para animais |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B11K | Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved |
Free format text: PRIORIDADE INTERNA DO PI0801222-9. |
|
B03G | Publication of an application: publication cancelled [chapter 3.7 patent gazette] |
Free format text: REFERENTE A RPI 1974 DE 04/11/2008. |
|
B03F | Publication of an application: publication of application definitely dismissed [chapter 3.6 patent gazette] |